Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02746445 · ClinicalTrials.gov registry record
A Longitudinal Study on the Safety and Efficacy for Subjects With ASD Who Received MeRT
A clinical trial of Autistic Disorder, sponsored by Wave Neuroscience.
- Completed
- Registry status
- 11
- Enrollment target
- 1
- Study location
NCT02746445: Completed study of Autistic Disorder, sponsored by Wave Neuroscience.
NCT02746445 is a study of Autistic Disorder that has completed, run by Wave Neuroscience. The registered enrollment target is 11 participants, below the 113-participant average among 27 other Autistic Disorder trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02746445, a study of Autistic Disorder, has completed, sponsored by Wave Neuroscience.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to continue to evaluate the long-term effectiveness of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in children with Autism Spectrum Disorder (ASD). No active MeRT treatment will be performed in this study.
Primary Outcome
Symptom reduction in ASD will be measured using the arithmetic reduction in the CARS total score between two time points BL and week 104 (or Early Termination)
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
California
- Brain Treatment Center - Newport Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2016-04 |
| Est. Completion | 2017-04 |
What the finished NCT02746445 record still lists
NCT02746445 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 113-participant average among 27 other Autistic Disorder trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Autistic Disorder appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT02746445 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02746445 about?
NCT02746445 is a clinical study titled "A Longitudinal Study on the Safety and Efficacy for Subjects With ASD Who Received MeRT". The purpose of this study is to continue to evaluate the long-term effectiveness of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in children with Autism Spectrum Disorder (ASD). No active MeRT treatment will be performed in this study.
What is the current status of trial NCT02746445?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2016-04. Estimated completion is 2017-04.
What conditions does trial NCT02746445 study?
This clinical trial studies the following conditions: Autistic Disorder.
What interventions are being tested in trial NCT02746445?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT02746445?
This trial is sponsored by Wave Neuroscience, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02746445 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autistic Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02746445's enrollment target sits among peer trials
11 28th of 27 the lowest of 27 other Autistic Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autistic Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
RECRUITING
-
Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)
RECRUITING · NA
-
Randomized Clinical Trial of TUNE In 3.0: A Social/Emotional Program for Adults With Autism Spectrum Disorder
RECRUITING · NA
-
Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders
RECRUITING · NA
-
Project AFECT (Autism Family Empowerment Coaching and Training Program)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia